Latest Hoffmann-La Roche Stories
According to court documents, on April 18th, 2012, the Accutane side effects lawsuit filed by Alton Herbert was transferred to the current Accutane Multi District Litigation (MDL 1626) in the Middle District of Florida. Herbert filed the lawsuit on January 12th, 2012, in the U.S. District Court for the Eastern District of Louisiana (case no. ATL-L-5981-11-MT) claiming that, after taking the generic Accutane “Claravis”, he was diagnosed with inflammatory bowel disease (Crohn's...
BRANFORD, Connecticut, April 24, 2012 /PRNewswire/ -- Roche announced today the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer Sets for comprehensive genetic variation detection in four key human genes using the company's 454 GS Junior [http://my454.com/products/gs-junior-system/index.asp ] and GS FLX Systems [http://www.454.com/products-solutions/product-list.asp ]. The sequence-based assays offer a new solution for cancer...
On March 14th, 2012 a New Jersey judge, Carol E. Higbee of the Atlantic County Superior Court, overseeing a consolidated Accutane inflammatory bowel disease lawsuit (case no. ATL-L-3361-04-MT) has affirmed the jury’s verdicts and denied manufacturer Hoffman-LaRoche’s request for a new trial. The jury awarded Gillian Gaghan $2 million in damages for the injuries she suffered as a consequence of using Accutane. Accutane (isotretinoin), a popular acne medication, was introduced in 1982...
WILTON, Conn., April 9, 2012 /PRNewswire/ -- Private Client Resources, LLC (PCR), the premier provider of private wealth aggregation and data-driven solutions for wealth managers, advisory firms, family offices and private banks, has announced the launch of an expanded version of the company's award-winning Palette Platform(TM) to meet the growing needs of advisors seeking partially outsourced service solutions. PCR's hybrid solution, unique to the marketplace, will give advisors...
PENZBERG, Germany, March 28, 2012 /PRNewswire/ -- Roche's xCELLigence RTCA [https://www.roche-applied-science.com/sis/xcelligence/index.jsp?&id=xcect_000000 ] System is being used in the European Union's SEURAT (Safety Evaluation Ultimately Replacing Animal Testing) initiative to run five years from 2011 to 2016. As of 2013, animal experiments are no longer permitted for use in toxicology testing in the cosmetic industry. Significant progress has been made in recent years...
NEW YORK, March 28, 2011 /PRNewswire/ -- Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized and non-invasive cancer diagnostics, today announced that Kapil Dhingra, M.B, B.S., has joined the Exosome Diagnostics Board of Directors. "I am delighted to join the Board of Exosome Diagnostics at this critical stage in the evolution of the company. Cancer treatment is becoming increasingly personalized. The ability to perform...
GenturaDx has been awarded its fifth patent from the U.S. patent office, which covers aspects of the sample cassette utilized by the IDbox™. Hayward, Calif. (PRWEB) March 23, 2012 GenturaDx, a molecular diagnostics company, announced today that is has been awarded its fifth patent from the U.S. patent office (U.S. Patent No. 8,124,024), which covers aspects of the sample cassette utilized by the IDbox™. The GenturaDx cassette design is part of the company’s proprietary fully...
MOUNTAIN VIEW, Calif., March 22, 2012 /PRNewswire/ -- Based on its recent analysis of new products within the life sciences market, Frost & Sullivan recognizes iCubate with the 2012 North American Frost & Sullivan Award for Product Innovation. iCubate has developed the new version of a "gold standard" polymerase chain reaction (PCR) instrument. The revolutionary instrument has the ability to perform simple extraction, amplification, and detection, all in a multiplexed,...
CHICAGO, March 16, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Roche Holdings Ltd. (OTC: RHHBY), Illumina, Inc. (Nasdaq: ILMN), Leap Wireless International Inc. (Nasdaq: LEAP), Clearwire Corporation (Nasdaq: CLWR) and Sprint Nextel Corp. (NYSE: S). (Logo:...
According to court documents, on February 27th, 2012 the New Jersey Supreme Court ruled that Kamie S. Kendall, the plaintiff in a $10.5 million lawsuit over Accutane, did not miss the state's two-year statute of limitations when she filed the suit in 2005 (A-73-2010 – 066802). Accutane (isotretinoin), a popular acne medication introduced in 1982, is manufactured by Hoffman-LaRoche, Inc. Kendall, who accuses Accutane for her ulcerative colitis, started taking Accutane for her acne in...
